EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss of $0.62, Revenues Beat

Go back to EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss of $0.62, Revenues Beat
(NASDAQ: EYPT) Delayed: 13.53 --0 (-0%)
Previous Close $13.53    52 Week High
Open $13.53    52 Week Low
Day High $13.53    P/E N/A 
Day Low $13.53    EPS
Volume 205